<DOC>
	<DOCNO>NCT00646113</DOCNO>
	<brief_summary>To evaluate 5-year survival , functionality safety OsseoSpeed™ 3.0 mm diameter implant use single tooth crown position 12 , 22 , 31 , 32 , 41 42 . The primary hypothesis implant survival 5 year equal observe comparable implant current literature .</brief_summary>
	<brief_title>Study Evaluating OsseoSpeed™ Narrow Implant Upper Lower Anterior Jaw</brief_title>
	<detailed_description />
	<mesh_term>Jaw , Edentulous , Partially</mesh_term>
	<mesh_term>Jaw , Edentulous</mesh_term>
	<criteria>Provision inform consent Aged 1870 year enrolment History edentulism study area least two month Presence natural tooth root adjacent study implant position Deemed investigator bone height width suitable 3.0 mm diameter study implant Deemed investigator likely present initially stable implant situation Unlikely able comply study procedure , judge investigator Uncontrolled pathologic process oral cavity Known suspect current malignancy History radiation therapy head neck region History chemotherapy within 5 year prior surgery Systemic local disease condition could compromise postoperative heal and/or osseointegration , deem investigator Uncontrolled diabetes mellitus Corticosteroids medication could influence postoperative healing and/or osseointegration Smoking 10 cigarette per day Present alcohol and/or drug abuse Involvement planning conduct study ( applies Astra Tech staff staff study site ) Previous enrolment present study Simultaneous participation another clinical study , participation clinical study last week prior enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>